articleThe LancetAug 1, 2011BRONZE OA

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

EBEarly Breast Cancer Trialists' Collaborative Group (EBCTCG)

University of Oxford

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

3,049
total citations
FWCI
59.13
Percentile
100%
References
35
Citations per year

Authors

1
  • EB
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)Corresponding

    University of Oxford

Topics & keywords

Keywords
  • Tamoxifen
  • Breast cancer
  • Medicine
  • Internal medicine
  • Oncology
  • Meta-analysis
  • Hormone receptor
  • Cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding